Cellmid $0.056
(0%)
|
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 14 November 2026 at 4:11am | ||||
CELLMID LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (14-Nov) $12,332,152 (1,885th) |
Close (15-Dec) $0.056 |
Volume (15-Dec) 0 |
Shortsold (8-Dec) 13,278 (0.02%) (428th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.024 |
Investor Briefing and Presentation
CDY released this announcement to the ASX on 3 May 2021, 9:35. The announcement is not marked as price sensitive, and is 22 page(s) in length and 1.49MB in size.
You can view all announcements from CDY and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from CDY | |
|---|---|
| Results of Meeting | 9 December 2021, 13:11 |
| AGM Presentation to Shareholders | 9 December 2021, 11:03 |
| Release of Shares from Voluntary Escrow | 7 December 2021, 18:47 |
| Investor Briefing and Presentation | 3 May 2021, 9:35 |
| Chinese Import Permits Received | 30 April 2021, 9:53 |
| Investor Briefing | 29 April 2021, 17:12 |
| Agreement Signed for Sale of Lyramid Limited | 29 April 2021, 11:31 |
If you were already registered, log in here.
If you were already registered, log in here.